Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Sparrow Pharmaceuticals Expands Phase 2 Clinical Trial of SPI-62 with Prednisolone for Polymyalgia Rheumatica with Second Cohort
Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs […]
Korro Bio and Genevant Sciences Enter into Collaboration Agreement to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency
Korro Bio, a leading RNA editing company focused on the discovery and development of novel […]
Catherine Bianchi, Saint-Gobain, on Pharmaceutical Products
In the video, Catherine Bianchi, Marketing Group Leader of Bioprocess Solutions at Saint-Gobain, introduces the […]
Biocytogen Announces RenLite™ Licensing Agreement with Janssen
Biocytogen Pharmaceuticals, have announced the signing of a non-exclusive license agreement with Janssen Biotech, one […]
Venatorx Pharmaceuticals Appoints Tomas J. Heyman as Non-Executive Chairman
Venatorx Pharmaceuticals, a private, clinical-stage pharmaceutical company focused on improving health outcomes for patients with […]
JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma
JW Therapeutics, an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell […]
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Capsida Biotherapeutics today announced the appointment of Susan Catalano as the company’s Chief Scientific Officer (CSO). Dr. […]
Chris Philpott, Boddingtons, on Injection Molding
In this video, Chris Philpot, the Commercial and Technical Manager at Boddingtons, highlights the capabilities […]
Personalis Selected for Clinical Research by AstraZeneca After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
Personalis, a leader in advanced genomics for precision oncology, today announced it will continue its […]
MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules
MIMETAS, a leading company in the field of organ-on-a-chip-based disease models, announces that it has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more